Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 28;31(1):1-7.
doi: 10.4014/jmb.2010.10021.

Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms

Affiliations
Review

Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms

Ying Luo et al. J Microbiol Biotechnol. .

Abstract

Bacterial biofilm is a community of bacteria that are embedded and structured in a self-secreted extracellular matrix. An important clinical-related characteristic of bacterial biofilms is that they are much more resistant to antimicrobial agents than the planktonic cells (up to 1,000 times), which is one of the main causes of antibiotic resistance in clinics. Therefore, infections caused by biofilms are notoriously difficult to eradicate, such as lung infection caused by Pseudomonas aeruginosa in cystic fibrosis patients. Understanding the resistance mechanisms of biofilms will provide direct insights into how we overcome such resistance. In this review, we summarize the characteristics of biofilms and chronic infections associated with bacterial biofilms. We examine the current understanding and research progress on the major mechanisms of antibiotic resistance in biofilms, including quorum sensing. We also discuss the potential strategies that may overcome biofilm-related antibiotic resistance, focusing on targeting biofilm EPSs, blocking quorum sensing signaling, and using recombinant phages.

Keywords: Biofilm; antibiotic resistance mechanisms; control strategies; quorum sensing.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have no financial conflicts of interest to declare.

Figures

Fig. 1
Fig. 1. Structure and life cycle of bacterial biofilms.
(1) Initial surface attachment of planktonic bacteria cells; (2) cell to cell adhesion and biofilm growth; (3) biofilm maturation; and (4) cell detachment and biofilm dispersal. Polysaccharides, nucleic acids, protein and lipids are major components of biofilms. The biofilm form of bacteria is resistant to many environmental insults, including UV light, antibiotics, and salinity. Anti-biofilm methods mentioned in this review are shown, indicated with green arrows at the locations where they act.

References

    1. Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat. Rev. Microbiol. 2017;15:740–755. doi: 10.1038/nrmicro.2017.99. - DOI - PMC - PubMed
    1. Flemming H-C, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat. Rev. Microbiol. 2016;14:563–575. doi: 10.1038/nrmicro.2016.94. - DOI - PubMed
    1. de Vos WM. Microbial biofilms and the human intestinal microbiome. Npj Biofilms Microbiomes. 2015;1:15005. doi: 10.1038/npjbiofilms.2015.5. - DOI - PMC - PubMed
    1. Percival SL, Suleman L, Vuotto C, Donelli G. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J. Med. Microbiol. 2015;64:323–334. doi: 10.1099/jmm.0.000032. - DOI - PubMed
    1. Miquel S, Lagrafeuille R, Souweine B, Forestier C. Anti-biofilm activity as a health issue. Front. Microbiol. 2016;7:592. doi: 10.3389/fmicb.2016.00592. - DOI - PMC - PubMed

MeSH terms

Substances